Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Very Strong
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Telephone
61.3.9095.3036
Address
Level 2 971 Burke Road Camberwell, Victoria (VIC) 3124
Description
MedAdvisor Ltd. engages in the provision of pharmacy-driven, innovative patient engagement solutions that simplify the patient medication journey to empower better health. It operates through the following segments: Australia and New Zealand Operations, the United States Operations, the United Kingdom Operations, Asia Operations, and Corporate. The company was founded by Joshua Swinnerton in 2010 and is headquartered in Camberwell, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.08 - 0.59
Trade Value (12mth)
AU$75,891.00
1 week
35.42%
1 month
41.3%
YTD
-43.48%
1 year
-60.61%
All time high
1.73
EPS 3 yr Growth
-103.20%
EBITDA Margin
5.60%
Operating Cashflow
$5m
Free Cash Flow Return
9.20%
ROIC
1.40%
Interest Coverage
3.60
Quick Ratio
0.70
Shares on Issue (Fully Dilluted)
604m
HALO Sector
Technology
Next Company Report Date
27-Aug-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
07 May 25 |
Evaluation of Strategic Options Update
×
Evaluation of Strategic Options Update |
07 May 25 |
Pause in Trading
×
Pause in Trading |
07 May 25 |
Trading Halt
×
Trading Halt |
02 May 25 |
Court Orders Granted & Trading to Resume
×
Court Orders Granted & Trading to Resume |
02 May 25 |
Reinstatement to Official Quotation
×
Reinstatement to Official Quotation |
01 May 25 |
Notification regarding unquoted securities - MDR
×
Notification regarding unquoted securities - MDR |
30 April 25 |
MDR 3Q FY25 4C and Quarterly Activity Report
×
MDR 3Q FY25 4C and Quarterly Activity Report |
30 April 25 |
MDR 3Q FY25 Presentation
×
MDR 3Q FY25 Presentation |
29 April 25 |
Suspension from Quotation
×
Suspension from Quotation |
29 April 25 |
MedAdvisor Solutions 3Q FY25 Investor Webinar
×
MedAdvisor Solutions 3Q FY25 Investor Webinar |
28 April 25 |
Extension of MDR Share Purchase Plan
×
Extension of MDR Share Purchase Plan |
23 April 25 |
Cleansing notice
×
Cleansing notice |
23 April 25 |
Trading Halt
×
Trading Halt |
15 April 25 |
Extension of MDR Share Purchase Plan
×
Extension of MDR Share Purchase Plan |
10 April 25 |
Change in substantial holding
×
Change in substantial holding |
10 April 25 |
Change in substantial holding
×
Change in substantial holding |
07 April 25 |
MDR Share Purchase Plan Offer Opens
×
MDR Share Purchase Plan Offer Opens |
07 April 25 |
Application for quotation of securities - MDR
×
Application for quotation of securities - MDR |
03 April 25 |
Final Directors Interest Notice - L Jenkinson
×
Final Directors Interest Notice - L Jenkinson |
01 April 25 |
MedAdvisor Announces Corporate Update and Equity Raising
×
MedAdvisor Announces Corporate Update and Equity Raising |
01 April 25 |
Capital Raise Presentation
×
Capital Raise Presentation |
01 April 25 |
Proposed issue of securities - MDR
×
Proposed issue of securities - MDR |
01 April 25 |
Proposed issue of securities - MDR
×
Proposed issue of securities - MDR |
01 April 25 |
Proposed issue of securities - MDR
×
Proposed issue of securities - MDR |
31 March 25 |
Trading Halt
×
Trading Halt |
11 March 25 |
Change in substantial holding
×
Change in substantial holding |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.